01.11.2012 | Letter to the Editor
Fasting glucose level reduction induced by imatinib in chronic myeloproliferative disease with TEL-PDGFRβ rearrangement and type 1 diabetes
Erschienen in: Annals of Hematology | Ausgabe 11/2012
Einloggen, um Zugang zu erhalten